O-lauroyl-L-carnitine

Metabolite details

Identifier

FUJLYHJROOYKRA-QGZVFWFLSA-N

InChI Key

FUJLYHJROOYKRA-QGZVFWFLSA-N

IUPAC name

(3R)-3-(dodecanoyloxy)-4-(trimethylazaniumyl)butanoate

Preferred name

O-lauroyl-L-carnitine

INN name

—

Synonym

(3R)-3-(dodecanoyloxy)-4-(trimethylammonio)butanoate

ChEBI

CHEBI:77086

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Metabolomic Profile of Diet-Induced Obesity Mice in Response to Human and Small Humanin-like Peptide 2 Treatment
• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Integrated Analyses of the Gut Microbiota, Intestinal Permeability and Serum Metabolome Phenotype in Rats with Alcohol Withdrawal Syndrome
• Metabolic characterization of the natural progression of chronic hepatitis B (Biogenic amine and Acyl-carnitine assays).
• Integrated multi-omics analysis of adverse cardiac remodeling and metabolic inflexibility upon ErbB2 and ERRα deficiency.

Observed in differential profiles

• Water_vs_HNG
• Water_vs_HNG
• Water_vs_HNG
• Water_vs_HNG
• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• Alcohol_Treatment_vs_Control
• Control_vs_Immune_Tolerant
• WT_vs_ErbB2_KI